Radio Télévision Suisse consulted our co-founder and CSO Laurent Mouchiroud about today’s advances in the field of aging and longevity research for the monthly health reportage.
We are delighted to announce our participation once again in the Swiss Biotech Day.
Meet us at Longevity Leaders World Congress and learn more about our pioneer Organism-on-Chip technology
Our CSO and co-founder Laurent Mouchiroud will present Nagi’s pioneer technology used in a successful project for Bayer CropScience at the prestigious SOT Annual Meeting.
Meet the first Organism-on-Chip technology on Friday 25th March at 14:30 CET at the TechTour Future22 event.
Nagi Bioscience was selected as a finalist of the prestigious W.A. De Vigier Stiftung startup competition in 2021.
Nagi Bioscience was selected as part of the EU-funded “HealthAge” project.
Nagi Bioscience was awarded an Innosuisse Innovation Project in 2020.
Nagi Bioscience was named as a TOP 100 Swiss startups and TOP 10 newcomers of 2020. And we did it again this year 2022! We have been nominated for TOP 100 Swiss…
Nagi Bioscience was selected by the prestigious Swiss economic newspaper Bilan among the Top 50 startups in which to invest in 2020.